京漢股份(000615.SZ)擬變更公司名稱為“奧園美谷科技股份有限公司”
格隆匯 10 月 26日丨京漢股份(000615.SZ)公佈,結合公司發展現狀和未來戰略方向,公司擬變更公司中文名稱、公司英文名稱、證券簡稱及英文簡稱,具體如下:
變更前:中文名稱為京漢實業投資集團股份有限公司;英文名稱為Kinghand Industrial InvestmentGroup Co.,Ltd.;證券簡稱為 京漢股份;英文簡稱為Kinghand。
擬變更後:中文名稱為奧園美谷科技股份有限公司;英文名稱為Aoyuan Beauty Valley Technology Co.,Ltd.;證券簡稱為奧園美谷;英文簡稱為Aoyuan Beauty Valley。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.